期刊文献+

组织脂质抽提方法评估与应用 被引量:1

Evaluation and application of lipid extraction methods from tissues
原文传递
导出
摘要 目的比较3种常用的组织三酰甘油(TG)、总胆固醇(TC)抽提方法。方法脂质提取分别采用3种方法。A:氯仿-甲醇抽提,B:庚烷-异丙醇-聚山梨酯20抽提,C:叔醇-Triton X-100-甲基乙醇抽提。采用氧化酶法检测混合人血清、普食或高脂饲养大鼠肝组织TG和TC水平,自动生化仪或手工比色测定。结果在3种方法中,A法较其他方法耗时长;C法需手工测定。尽管3种方法的批内和批间差异无明显不同,方法A、B提取的TG、TC回收率随抽提溶液体积增大而增加,而C法回收率随抽提液体积增大而呈下降趋势。采用B法作组织抽提,普食大鼠肝脏中TG、TC的抽提量不随抽提液体积的改变而变化,高脂大鼠肝脏TG、TC含量随抽提液体积增加而升高。进一步选用5 mL抽提液提取普食和高脂大鼠肝脏,高脂大鼠TG、TC含量均明显高于普食组(P<0.01)。结论 3种脂质抽提方法中,B法回收率高,自动化程度高、省时,适合肥胖大鼠肝脏脂质的抽提。用B法提取50 mg高脂肝脏脂质时,抽提溶液体积以5或7 mL为宜。 AIM To compare three common lipid extraction methods for triglycerides (TG) and total cholesterol (TC). METHODS Lipids were extracted using the following 3 methods: method A (chloroformmethanol extraction), method B (heptane-isopropanol-polysorbate extraction) and method C (tert-butyl alcohol- Triton X-100-ymethyl alcohol extraction). The concentrations of TG and TC were determined using enzymatic commercial kits by an automatic biochemical analyzer (method A and B) or manual operation (method C). RESULTS Among three methods, method A was the most time-consuming one and method C was the least automated one due to its manual operation. Recoveries of method A and B were both dose-dependently associated with volume of extraction solution, while a negative relationship existed between recovery and extraction liquid volume in method C. There were no significant differences in within-run CV and day-to-day CV among the three methods. When method B was used for lipid extraction, we found TG and TC content in liver from high fat diet fed rats were increased with the extraction volume, whereas those in liver from chow fed rats were not. More TG and TC were found in liver from high fat diet fed rats than those in liver from chow fed rats (P 〈 0.01 ). CONCLUSION Method B has the characteristics of higher precision, higher degree of automatization and less time-consuming, and is suitable for lipid extraction in livers from obese rats. A volume of 5 or 7 mL extraction solution is suitable for as much as 50 mg liver tissue.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2011年第6期457-461,共5页 Chinese Journal of New Drugs and Clinical Remedies
基金 国家自然科学基金项目(30971121) 上海市科学技术委员会重大项目(08dj1400601)
关键词 甘油三酯类 总胆固醇 脂质抽提 回收率 精确度 triglycerides total cholesterol lipid extraction recovery precision
  • 相关文献

参考文献2

二级参考文献37

  • 1Zierath JR, Ryder JW, Doebber T, Woods J, Wu M, Ventre J, et al. Role of skeletal muscle in thiazolidinedione insulin sensitizer (PPARgamma agonist) action. Endocrinology 1998; 139: 5034-41.
  • 2Robins S, Collins D, Wittes J, Papademetriou V, Deedwania P,Schaefer E, et al. Relation of gemfibrozil treatment and lipid levels with major coronary events. VA-HIT: a randomized con-trolled trial. J Am Med Assoc 2001, 285: 1585-91.
  • 3Diabetes Atherosclerosis Intervention Study Investigators. Effect of fenofibrate on progression of coronary artery disease in type 2 diabetes: The Diabetes Atherosclerosis Intervention Study,a randomised study. Lancet 2001; 357: 905-10.
  • 4Tang L, Yu J, Leng Y, Feng Y, Yang Y, Ji R. Synthesis and insulin-sensitizing activity of a novel kind of benzopyran derivative. Bioorg Med Chem Lett 2003; 13: 3437-40.
  • 5Chakrabarti R, Misra P, Vikramadithyan RK, Premkumar M,Hiriyan J, Datla SR, et al. Antidiabetic and hypolipidemic potential of DRF 2519-a dual activator of PPAR-alpha and PPAR-gamma. Eur J Pharmacol 2004; 491:195 206.
  • 6Haluzik M, Colombo C, Gavrilova O, Chua S, Wolf N, Chen M, et al. Genetic background (C57BL/6J versus FVB/N) strongly influences the severity of diabetes and insulin resistance in ob/ob mice. Endocrinology 2004; 145: 3258-64.
  • 7Ljung B, Bamberg K, Dahllof B, Kjellstedt A, Oakes ND, Ostling J, et al. AZ242, a novel PPARα/γ agonist with beneficial effects on insulin resistance and carbohydrate and lipid metabolism in ob/ob mice and obese Zucker rats. J Lipid Res 2002;43:1855-63.
  • 8Cha BS, Ciaraldi TP, Park KS, Carter L, Mudaliar SR, Henry RR.Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPARgamma agonists. Am J Physiol Endocrinol Metab 2005; 289: E151-9.
  • 9Sinha S, Perdomo G, Brown NF, O'Doherty RM. Fatty acidinduced insulin resistance in 16 myotubes is prevented by inhibition of activation and nuclear localization of nuclear factor kappa B. J Biol Chem 2004; 279: 41294-301.
  • 10Wiegman CH, Bandsma RH, Ouwens M, van der Sluijs FH, Havinga R, Boer T, et al. Hepatic VLDL production in ob/ob mice is not stimulated by massive de novo lipogenesis but is less sensitive to the suppressive effects of insulin. Diabetes 2003; 52: 1081-9.

共引文献12

同被引文献9

  • 1Li L. Yang Y. Yang G. et al. The role of JAZF1 on lipid metabolism and related genes in vitro. Metabolism. 2011. 60: 523-530.
  • 2Guo J. Bei W. Hu Y. et al. A new TCM formula FTZ lowers serum cholesterol by regulating HMG-CoA reductase and CYF7 Al in hyperlipidemic rats. J Ethnopharmacol , zou. 135: 299-307.
  • 3Eisele B. Budzinski R. Muller P. et al. Effects of a novel 2. 3- oxidosqualene cyclase inhibitor on cholesterol biosynthesis and lipid metabolism in vivo. J Lipid Res. 1997. 38:564-575.
  • 4De Hoff JL.Davidson LM. Kritchevsky D. An enzymatic assay for determining free and total cholesterol in tissue. Clin Chem. 1978. 24: 433-435.
  • 5葛可佑.中国营养科学全书.下册.北京:人民卫生出版社,2004.
  • 6Dobirisovd M.Frohlich J. Sedovd M. et al. Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography. J Lipid Res, zon, 52: 566-571.
  • 7Luboshitzky R. Herer P. Cardiovascular risk factors in middleaged women with subclinical hypothyroidism Neuro Endocrinol Lett. 2004. 25: 262-266.
  • 8Hadi NR. Al-Amran F, Hussein MA. et al. Evaluation of the effects of glimepiride (Amaryl) and repaglinide (novol-Jorm) on atherosclerosis progression in high cholesterol-fed male rabbits. J Cardiovasc Dis Res.2012.3:5-11.
  • 9Linton MF, Fazio S. Class A scavenger receptors, macrophages, and atherosclerosis. Curr Opin Lipidol. 2001. 12: 489-495.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部